Cher client, La page que vous souhaitez ouvrir est en phase de construction, vous trouverez ci-dessous la version anglaise. Merci! | |
Plasmidic siRNA Expression VectorsThese vectors are designed for mammalian transfection. They each carry a neomycin, hygromycin, or zeomycin resistance gene as a selectable marker, which can be used for establishing stable cell lines. The pRNAT vectors also carry a GFP marker (coral GFP or cGFP) under CMV promoter* control, which can be used to track transfection efficiency. They use regular or enhanced U6, or H1, or CMV promoters to drive siRNA expression. References:
Related Products and Services:
** Limited Use Label License: This H1.2 inducible promoter is covered by United States Patent Applications Nos. 60,505,677, owned by GenScript Corporation. The purchase of this product conveys to the buyer the limited, non-exclusive, non-transferable right (without the right to resell, repackage, or further sublicense) under these patent rights to perform the siRNA synthesis methods claimed in the patent application for research and development purposes solely in conjunction with this product. | |









